HLS Therapeutics Inc. (TSX:HLS)

HLS Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 21, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	144	151	125	126	318	487
Market Cap Growth	5.74%	20.52%	-1.00%	-60.28%	-34.71%	-15.01%
Enterprise Value	189.93	205.26	196.49	217.91	425.51	586.92
Last Close Price	4.59	4.82	3.93	3.95	9.82	15.00
PS Ratio	1.84	1.98	1.54	1.51	3.81	6.42
PB Ratio	1.76	1.78	1.22	0.98	1.87	2.40
P/TBV Ratio	2.46	2.46	1.76	1.30	2.54	3.00
P/FCF Ratio	5.20	6.49	10.91	6.05	13.86	23.51
P/OCF Ratio	5.15	6.41	10.89	6.04	13.83	23.45
EV/Sales Ratio	2.44	2.69	2.42	2.61	5.10	7.74
EV/EBITDA Ratio	7.62	9.16	7.86	10.70	19.95	19.50
EV/FCF Ratio	6.88	8.84	17.14	10.44	18.56	28.35
Debt / Equity Ratio	0.78	0.84	0.94	0.93	0.80	0.62
Debt / EBITDA Ratio	2.73	3.15	3.86	5.93	6.36	4.21
Debt / FCF Ratio	2.30	3.04	8.42	5.79	5.92	6.13
Net Debt / Equity Ratio	0.57	0.65	0.70	0.71	0.63	0.49
Net Debt / EBITDA Ratio	1.99	2.44	2.86	4.50	5.05	3.33
Net Debt / FCF Ratio	1.68	2.35	6.24	4.39	4.70	4.83
Asset Turnover	0.42	0.37	0.31	0.28	0.24	0.21
Inventory Turnover	1.34	1.17	0.97	0.83	0.56	0.41
Quick Ratio	0.71	0.75	1.10	1.22	1.02	1.18
Current Ratio	1.00	1.11	1.57	1.65	1.42	1.58
Return on Equity (ROE)	-17.12%	-18.69%	-23.26%	-24.69%	-16.50%	-7.95%
Return on Assets (ROA)	-3.79%	-3.56%	-3.62%	-7.28%	-7.18%	-2.47%
Return on Invested Capital (ROIC)	-4.54%	-4.25%	-4.35%	-8.61%	-8.22%	-2.79%
Return on Capital Employed (ROCE)	-4.96%	-4.41%	-3.31%	-8.43%	-8.15%	-2.50%
FCF Yield	19.22%	15.42%	9.17%	16.52%	7.21%	4.25%
Dividend Yield	-	0.00%	0.00%	2.49%	2.11%	1.34%
Payout Ratio	-	0.00%	0.00%	-8.71%	-21.03%	-39.05%
Buyback Yield / Dilution	-0.10%	0.98%	1.31%	0.52%	-0.77%	-1.48%
Total Shareholder Return	-0.10%	0.98%	1.31%	3.02%	1.34%	-0.14%

Updated May 15, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.